CD4+/CD56+ Hematodermic TumorMarco Herling, Dan Jones|American Journal of Clinical Pathology|2007Cited by 172
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemiaPhilipp B. Staber, Claire Dearden, Ulrich Jaeger et al.|Blood|2019Cited by 161
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLLAlexandra Schrader, Marco Herling|Nature Communications|2018Cited by 105
JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLLLinus Wahnschaffe, Marco Herling|Cancers|2019Cited by 66
Proteogenomics refines the molecular classification of chronic lymphocytic leukemiaSophie A. Herbst, Sascha Dietrich, Ioannis Siavelis et al.|Nature Communications|2022Cited by 42